medicare glp 1 coverage weight loss CMS Issues Guidance on GLP-1 Anti-Obesity Drugs The GLP-1 Access Gap: Mapping

GLP-1 receptor agonists reduce appetite and food intake, potentially leading to micronutrient deficiencies rather than causing direct malabsorption

Clinical Evidence on Probiotics During GLP-1 Therapy Peer-reviewed studies specifically evaluating probiotic safety and efficacy during semaglutide or tirzepatide treatment remain sparse

GLP-1 plays a crucial role in regulating blood sugar levels by stimulating insulin secretion, reducing glucagon release (a hormone that raises blood sugar), slowing down gastric emptying, and increasing the feeling of fullness (satiety)

Wegovy was approved to treat obesity in 2021

Studies show that Metformin may encourage enzymes such as AMPK, which are crucial to the maintenance of energy homeostasis at a cellular level, thus enhancing cell life

Pharmacological options include drugs targeting lipid digestion and absorption, carbohydrate metabolism, or increased energy expenditure